A detailed history of Orion Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Orion Capital Management LLC holds 32 shares of VRTX stock, worth $15,051. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32
Previous 32 -0.0%
Holding current value
$15,051
Previous $13,000 7.69%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$338.18 - $362.46 $10,821 - $11,598
32 New
32 $11,000
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $9,063 - $10,339
32 New
32 $10,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Orion Capital Management LLC Portfolio

Follow Orion Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Capital Management LLC with notifications on news.